Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» #ASH17: Verastem’s AbbVie castoff is headed for the FDA — even after missing overall survival goal
#ASH17: Verastem’s AbbVie castoff is headed for the FDA — even after missing overall survival goal
#ASH17: Verastem’s AbbVie castoff is headed for the FDA — even after missing overall survival goal
Submitted by
admin
on December 10, 2017 - 11:22pm
Source:
Endpoints
News Tags:
ASH17
AbbVie
Verastem
FDA
duvelisib
chronic lymphocytic leukemia
Headline:
#ASH17: Verastem’s AbbVie castoff is headed for the FDA — even after missing overall survival goal
Do Not Allow Advertisers to Use My Personal information
